VAD implantation is a great procedure, however there are
some downsides. Patients must always
carry around their 2.2 kg control/power mechanisms, they are bombarded each day
with checkup calls from medical staff, and their drive lines are associated
with a high risk of infection. Since the
drive lines lead right to the heart from the outside of the body, physicians
refer to these drive lines as infection highways to the heart. The patients must be on anticoagulants for
the rest of their lives as embolisms are a common occurrence since the VAD
rotors cause hemolysis and blood clots are extremely dangerous and can lead to stroke
or myocardial infarction.
After the VAD
lecture, Dr. Hanke took us to see some of her patients in ward 15. In one patient, we were given the opportunity
to listen the whirring of their LVAD using a stethoscope. In another patient, whom we would later in
the day watch as he received a VAD implantation, we examined his symptoms of
left heart failure. His symptoms
included edema as a result of decompensation altering the pressure dynamics in his
blood vessels causing fluid to leak into the interstitial spaces of his
body. Gravity pulled the fluid into his
hands and feet causing them to become very swollen, a symptom known as pedal
edema. Fluid accumulated in his
abdominal region, a symptom known as ascites, and in his face as well. His cheeks were also purple. When blood cells are saturated with oxygen,
they gain a bright red color and, when they do not contain oxygen, they are a
dark purple color. Since the cheeks are
a very thin layer of epithelial cells, the color of blood passing through the vessels
behind them is visible and indicates the blood’s oxygen saturation. The purple color indicates the blood moving
through them did not contain oxygen.
This can be attributed to many things, but in this case it was likely edema
in the pulmonary arteries was inhibiting gas exchange in the alveoli.
Once we finished
meeting some of the patients, we scrubbed in at the OR and watched two
procedures, a valve replacement, and a coronary artery bypass graft, or CABG. Both procedures were high risk, so we had to
watch from the far side of the room. It
was an experience being able to watch the surgeons as they performed the
operation, however as we were far away from the action, not much was learned of
the operations themselves. After,
watching parts of the two procedures, we put on our regular clothes and went
back upstairs to debrief with Dr. Hanke.
Interestingly enough, the day before this trip to the Hanover hospital,
I had gone to a biomedical research facility and learned about catheterized
valve replacements. The engineers who
were working on creating the catheterized valves were very enthusiastic about
them and their reliability in vivo. The
valve replacement we watched was not catheterized and was relatively much more
invasive than the alternative as they had to crack the sternum and open the thoracic
cavity to expose the heart. I asked Dr.
Hanke if she had ever performed a catheterized valve replacement and she
replied she had, however that they were not very effective. I learned they were not very effective for one
particular reason. They were performed only
on patients who were too weak to survive a more invasive procedure. For this reason, the data they have on the
catheterized valve replacement procedures may not be reliable because the
patients receiving them are in a worse condition to begin with as opposed to
their more healthy counterparts receiving the valve replacements in the more
traditional fashion.
No comments:
Post a Comment